![Jason Campagna](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Campagna
Hoofd Techniek/Wetenschap/O&O bij
INVENTIVA
Profiel
Jason A. Campagna currently works at Inventiva SA, as Chief Medical Officer & President-Research from 2025.
Dr. Campagna also formerly worked at Annovation BioPharma, Inc., as Director, Profibrix BV, as Managing Director, Altus Copper Corp., as Independent Director from 2021 to 2023, The Medicines Co., as Senior VP-Surgery & Perioperative Care, Intercept Pharmaceuticals, Inc., as Chief Medical Officer & Senior Vice President from 2019 to 2021, Q32 Bio, Inc., as Chief Medical Officer from 2021 to 2025, and Q32 Bio Operations, Inc., as Chief Medical Officer.
Dr. Campagna received his undergraduate degree, graduate degree, and doctorate degree from the University of Miami.
Actieve functies van Jason Campagna
| Bedrijven | Functie | Begin |
|---|---|---|
| INVENTIVA | Hoofd Techniek/Wetenschap/O&O | 30-07-2025 |
Eerdere bekende functies van Jason Campagna
| Bedrijven | Functie | Einde |
|---|---|---|
| ALTUS COPPER CORP. | Directeur/Bestuurslid | 31-03-2023 |
| INTERCEPT PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 05-03-2021 |
| THE MEDICINES COMPANY | Corporate Officer/Principal | 01-08-2016 |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Jason Campagna
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
7
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Annovation BioPharma, Inc.
 Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products in the field of anesthesia, sedation and sleep | Health Technology |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology Develops and markets products for the hemostasis and regenerative medicine markets | Health Technology |
Inventiva SA
 Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Health Technology |
Plantable Health, Inc.
 Plantable Health, Inc. Pharmaceuticals: OtherHealth Technology Produces and sells plant-based meal products | Health Technology |
